Physical health assessment and monitoring in long-term mental health care

Similar documents
Mental Health Clinical Pathways Group. The Case for Change

Physical Health Checks

Why are NICE guidelines and standards important and relevant to us?

Cardiovascular Risk Assessment and Management Making a Difference

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Physical Health Management: Why it s important for adolescents and young adults in mental health services

OCCG SERVICE SPECIFICATION (2018/19) Improving Physical Health in Patients with a Severe Mental Illness

NAS NATIONAL AUDIT OF SCHIZOPHRENIA. Second National Audit of Schizophrenia What you need to know

How Good a Doctor? Physical Health Care in a Forensic Setting. Dr. Alan Cohen FRCGP

Guidelines on cardiovascular risk assessment and management

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update)

Established Risk Factors for Coronary Heart Disease (CHD)

Severe Mental Illness and Diabetes. Charlie Place

SCHEDULE 2 THE SERVICES

CYNLLUN CODI CALON/UPLIFTING HEART PROJECT

Diabetes, Diet and SMI: How can we make a difference?

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Volume 2; Number 11 July 2008

The links between physical health in mental health

Improving Medication Safety in Mental Health

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only)

Michael J. Bailey, M.D. OptumHealth Public Sector

Understanding the metabolic syndrome

Hearts and Minds An ECG Update. Tuesday 18 th November The Met Hotel, Leeds

PLEASE REMEMBER TO BRING TO EACH APPOINTMENT

The Metabolic Syndrome: Is It A Valid Concept? YES

MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES

AUTONOMIC FUNCTION IS A HIGH PRIORITY

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Specialised Services Commissioning Policy. CP29: Bariatric Surgery

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Metabolic Monitoring, Schizophrenia Spectrum Illnesses, & Second Generation Antipsychotics

Supplementary Online Content

Introduction. Objectives. Psychotropic Medications & Cardiometabolic Risk

More than We Bargained For: Metabolic Side Effects of Antipsychotic Medications

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

New indicators to be added to the NICE menu for the QOF and amendments to existing indicators

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

Chronic Benefit Application Form Cardiovascular Disease and Diabetes

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Optimizing Health While Aging with HIV

National NHS patient survey programme Survey of people who use community mental health services 2014

POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK

Diabetes. Ref HSCW 024

Clinical. High Dose Antipsychotic Prescribing Procedures. Document Control Summary. Contents

QOF Indicator DM013:

The Brain and the Body: Medical Comorbidities in Psychiatric Illness. Kate Miley, CNP Psychiatric Nurse Practitioner, HCMC Adult Psychiatry Clinic

Minimising the Impact of Medication on Physical Health in Schizophrenia

Dr Kathy Greenwood & Remy Gray

ASSeSSing the risk of fatal cardiovascular disease

Type 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice.

ADHD and Adverse Health Outcomes in Adults

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)

POMH-UK QUALITY IMPROVEMENT PROGRAMME LITHIUM MONITORING. Thomas R. E. Barnes

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine

Collaborating, Co-managing and Facilitating Metabolic Improvement in Patients with Severe Mental Illness (SMI)

POLICY DOCUMENT. Pharmacy MMG/MPG. Approved By and Date Medicines Management roup March March 2016

Authorised by Greater Medicines Management Group

CARE PATHWAYS. Allyson Ashley

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

Evidence Briefing for NHS Bradford and Airedale. Physical health monitoring for people with schizophrenia or other serious mental illness

APNA 27th Annual Conference Session 2036: October 10, 2013

Ischaemic Heart Disease

Outcomes of diabetes care in England and Wales. A summary of findings from the National Diabetes Audit : Complications and Mortality reports

National Diabetes Audit

National Diabetes Audit, Report 1: Care Processes and Treatment Targets

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

Rick Fox M.A Health and Wellness Specialist

PHYSICAL ASSESSMENT AND EXAMINATION OF PATIENTS/CLIENTS POLICY

ADDRESSING CHRONIC DISEASES

Weight management IN ADULTS ASSESS MANAGE MONITOR MAINTAIN. Proceed to stage 2: Assess. Reassess. Obese. Overweight

Patient Group Direction for the Supply of Orlistat (Xenical) from Designated Community Pharmacies

National Paediatric Diabetes Audit

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group

14/15 Threshold 15/16 Points 15/16. Points. Retired Replaced by NM82/AF007. Replacement NO CHANGE

Service Specification: Bristol and South Gloucestershire Specialist Substance Misuse Treatment Service January 2016

THE METABOLIC SYNDROME

Effective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.

Of those with dementia have a formal diagnosis or are in contact with specialist services. Dementia prevalence for those aged 80+

NHS Health Check Training for Healthy Living Centre Staff and Colleagues. June 2015 Amanda Chappell

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016

PATIENT GROUP DIRECTION FOR THE SUPPLY OF ORLISTAT BY COMMUNITY PHARMACISTS

2013 Hypertension Measure Group Patient Visit Form

Elements for a Public Summary

SPECIALIST HEART CARE

This shared care protocol covers when atypical antipsychotics are prescribed for the treatment of

NHS Health Check Training for Healthy Living Centre Staff and Colleagues. June 2015 Amanda Chappell

MPharmProgramme. Hypertension (HTN)

Rehabilitation and Research Training Center on Secondary Conditions in Individuals with SCI. James S. Krause, PhD

CCG data collection for people with severe mental illness receiving a full physical health check and follow-up interventions in primary care

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Summary of 2011/12 QOF indicator changes, points and thresholds

Helen Williams Consultant Pharmacist for CV Disease - South London

The Stolen Years Mental Health and Smoking Action Report 22 April Emily James, Policy and Campaigns Officer

Faculty of Health Sciences Outcomes of campaigns for Palestine refugees with diabetes mellitus attending UNRWA health centers

Primary Prevention Patients aged 85yrs and over

Antipsychotic-Related Risk for Weight Gain and Metabolic Abnormalities During Development Christoph U. Correll, MD

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

What s new in cardiovascular disease risk assessment and management for primary care clinicians

Transcription:

Physical health assessment and monitoring in long-term mental health care Dr Alan Farmer Consultant Psychiatrist Worcestershire Mental Health Partnership NHS Trust

A brief questionnaire Current thoughts, partnerships and resources Handout 1

Things we know about people with mental illness 1. There is a high prevalence of physical health problems 2. Poor health has a major impact on mental stability and quality of life 3. There is reduced access to physical health care

Things we are starting to realise 1. The prevalence of physical health problems is rising faster than in the general population 2. People with physical health problems have higher mortality rates and those rates are increasing 3. Even when people access physical health care the quality is poorer

Increasing prevalence of physical health problems Difference from general population in prevalence of obesity in in-patients with schizophrenia 1988 +4.7% 2002 +14.7% Reist et al (2007) Prevalence of diabetes 1979-1995 parallel trends 1996-2001 0.7% increase per year in people with schizophrenia Basu & Meltzer 2006

Higher mortality rates People with psychosis age 25 to 44 have 6.6x higher cardiovascular mortality and die up to 25 years earlier. Highest in most developed countries Saha et al (2007), Parks et al (2006) People die sooner once developing a physical health problem Hippisley-Cox J et al (2006) Increasing prevalence of IHD even in areas where it is declining in the general population Lawrence (2003)

Five-year (non) survival rates Hippisley-Cox J et al (2006) A comparison of survival rates for people with mental health problems and the remaining population with specific conditions. Disability Rights Commission. Equal treatment: closing the gap, July 2006

Lawrence (2003)

Quality of care Deficits in quality of medical care seem to explain a substantial portion of the excess mortality experienced by patients with mental disorders after myocardial infarction Druss et al (2001) Medical and surgical hospitalizations for people with schizophrenia had at x2 several types of adverse events and up to x9 mortality rates Daumit et al (2006)

More people with mental illness die from cardiovascular disease than suicide.

Annual physical health checks (NSF for mental health/nice guidance) Blood pressure & weight/bmi Lifestyle advice (smoking/diet/exercise/alcohol/drugs) Urine/blood test to exclude diabetes Cholesterol check Medication side effect monitoring (Include thyroid function & creatinine if on lithium) Encourage screening in appropriate groups (cervical smears/mammography/hepatitis/hiv/high prolactin) Offer flu vaccination and contraceptive advice

Screening for metabolic side effects in AO clients Review of 1966 case records from 53 teams % with recorded measurement over last 12 months Documented diagnosis Documented treatment Estimated rates from Sz studies Blood pressure 26% Hypertension 6% 48% 27-36% (X5) Measure of obesity 17% Blood glucose 28% Diabetes 6% 62% 13% (X2) Plasma lipids 22% Dyslipidaemia 6% 37% 50% (X8) All of the above 11% Barnes et al (2007)

Review of prevalence/awareness of lifestyle & health problems in Worcestershire AO clients N=69/93 (all ECPA=145) Yes No Not sure Attended physical health screening assessment in the last 12 months 67 (60) 23 10 Do they take regular exercise? 59 (42) 41 0 Do they smoke? 74 (57) 26 0 Do they exceed recommended safe alcohol intake? 25 (17) 70 5 Any recreational drug use 23 (13) 70 7 Are they overweight? 33 (31) 62 5 Hypertension? 1 55 44 (30) High cholesterol levels? 16 38 46 (50) Diabetes 6 75 19 (15) Do they have breathing problems? 14 81 5 Contraception? 1 52 (43) 47 (55) Breast or testicular screening? 1 41 (32) 58 (63) Up to date cervical screening? (f=40) 15 58 (21) 27 (70)

Implications for clinical practice We need a thorough understanding of physical health risks. Psychiatrists function as front line physicians for inpatients and many out patients We must all prevent or reduce physical health risks in all our patients and promote screening, monitoring and health education in primary or secondary care We must all advocate for patients already experiencing physical health problems, making sure they are appropriately managed and followed-up

NICE guidelines The higher physical morbidity and mortality of service users with schizophrenia should be considered in all assessments. Whilst this would normally be expected to be the role of primary care services, secondary care services should nevertheless monitor these matters where they believe a service user may have little regular contact with primary care. NICE 2002

Meeting the challenge Practical considerations Handout 2

Understanding cardiovascular risk factors Non-modifiable risk factors Gender Family history Personal history Age Ethnicity Modifiable risk factors Obesity Smoking Glycaemic control Hypertension Dyslipidaemia

The Framingham Study 14 5 Odds ratios 12 10 8 6 Single Risk Factors Multiple Risk Factors 3 4 4 2 2 0 BMI >27 Smoking TC >220 Wilson et al. (1998) DM HTN Smoking + BMI Smoking + BMI + TC >220 Smoking + BMI + TC >220 + DM Smoking + BMI + TC >220 + DM + HTN

The Metabolic Syndrome Constellation of risk factors for cardiovascular disease Associated with increased insulin resistance Abdominal obesity: Waist circumference Men > 94 cm ( > 37 in) Women > 80 cm ( > 31 in) Plus 2 or more of the following factors Raised Triglyceride 1.7 mmol/l (or specific treatment for this lipid abnormality) Reduced HDL cholesterol Men < 1.03mmol/L Women < 1.29mmol/L Raised Blood pressure 130/85 mm Hg (or previously diagnosed hypertension) Fasting blood glucose 5.6mmol/L (or previously diagnosed Type II Diabetes)

Physical health monitoring (atypical antipsychotics) Initial visit 4 weeks 8 weeks 12 weeks 6- monthl y Annuall y Personal/family history Height/weight (BMI) X X X X X X X Blood pressure/ pulse Fasting plasma glucose ** Fasting lipid profile X X X X X (x) (x) X X X X X Barnett et al. (2007)

Challenges and opportunities Awareness raising, training, resources and multidisciplinary working to meet physical health needs Medication management involving patient education and choice Secondary care lifestyle interventions on in-patient units and hard to reach groups Liaison, communication and integration with physical health providers (primary and secondary health care) Increasing profile of physical health in CPA

Developing action plans Handout 3

Physical health monitoring references Barnes et al (2007) A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin, 33(6), 1397-1403 Barnett et al (2007) Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia. Journal of Psychopharmacology, 21(4), 357-373 Department of Health (2006) Choosing Health: supporting the physical health needs of people with severe mental illness. DH, August 2006 www.dh.gov.uk/assetroot/04/13/82/90/04138290.pdf NHS Clinical Knowledge Summaries: www.cks.library.nhs.uk/schizophrenia NICE public health guidance: Reducing the rate of premature deaths from cardiovascular disease and other smoking related diseases: finding and supporting those most at risk and improving access to services (September 2008) http://guidance.nice.org.uk/ph15 Rethink PHC: www.rethink.org/physicalhealthcheck Royal College of Psychiatrists: Physical health in mental health; Final report of a scoping group (January 2009) http://www.rcpsych.ac.uk/files/pdfversion/op67.pdf